Witnessing the stock’s movement on the chart, on Wednesday, Abbvie Inc (NYSE: ABBV) had a quiet start as it plunged -0.43% to $170.35, before settling in for the price of $171.09 at the close. Taking a more long-term approach, ABBV posted a 52-week range of $136.30-$207.32.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 11.76%. Meanwhile, its Annual Earning per share during the time was -5.77%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -1.61%. This publicly-traded company’s shares outstanding now amounts to $1.77 billion, simultaneously with a float of $1.77 billion. The organization now has a market capitalization sitting at $301.03 billion. At the time of writing, stock’s 50-day Moving Average stood at $193.07, while the 200-day Moving Average is $178.92.
Abbvie Inc (ABBV) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – General industry. Abbvie Inc’s current insider ownership accounts for 0.09%, in contrast to 72.82% institutional ownership. Preceding that transaction, on Aug 05 ’24, Company’s EXECUTIVE CHAIRMAN OF BOARD sold 66,500 for 186.52, making the whole transaction’s value amount to 12,403,580. This particular insider is now the holder of 446,599 in total.
Abbvie Inc (ABBV) Earnings and Revenue Records
Abbvie Inc’s EPS decrease for this current 12-month fiscal period is -1.61% and is forecasted to reach 12.13 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 8.31% through the next 5 years, which can be compared against the -5.77% growth it accomplished over the previous five years trading on the market.
Abbvie Inc (NYSE: ABBV) Trading Performance Indicators
Let’s observe the current performance indicators for Abbvie Inc (ABBV). It’s Quick Ratio in the last reported quarter now stands at 0.54. The Stock has managed to achieve an average true range (ATR) of 5.19. Alongside those numbers, its PE Ratio stands at $59.41, and its Beta score is 0.56. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.42. Similarly, its price to free cash flow for trailing twelve months is now 19.32.
In the same vein, ABBV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 2.87, a figure that is expected to reach 2.97 in the next quarter, and analysts are predicting that it will be 12.13 at the market close of one year from today.
Technical Analysis of Abbvie Inc (ABBV)
Going through the that latest performance of [Abbvie Inc, ABBV]. Its last 5-days volume of 9.78 million indicated improvement to the volume of 5.43 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 2.36% While, its Average True Range was 5.94.
Raw Stochastic average of Abbvie Inc (ABBV) in the period of the previous 100 days is set at 15.59%, which indicates a major rise in contrast to 1.86% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 62.80% that was higher than 29.92% volatility it exhibited in the past 100-days period.
